http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2385853-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d3de3009f45b5e91585dcf24dab6d3f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
filingDate 2000-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2314caeb28967742a8c41efc5441d6c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4ef70b8935557e09723abd659e1f72
publicationDate 2001-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2385853-A1
titleOfInvention Design of high affinity rnase h recruiting oligonucleotide
abstract The present invention relates to the field of bicyclic DNA analogues, e.g. L NA and LNA modifications, which are useful for designing oligomers that form hi gh affinity duplexes with complementary RNA wherein said duplexes are substrate s for RNase H. The oligonucleotides may be partially or fully composed of LNA analogues with very high affinity and ability to recruit RNase H. The implications are that oxy-LNA by itself may be used to construct novel antisense molecules with enhanced biological activity. Alternatively, oxy-LN A may be used in combination with non-oxy-LNA, such as standard DNA, RNA or other analogues, e.g. thio-LNA or amino-LNA, to create high affinity, RNase H recruiting anti-sense compounds without the need to adhere to any fixed desi gn.
priorityDate 1999-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11937
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22501384
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9YGI5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5802
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9735431
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426184233
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100862683
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID107702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11819216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516404
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID488839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4AEE3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID436947
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135497479
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11936
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22605278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410390131
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13419
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18998
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO42446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66950
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410890490
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510188
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID284203
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21704
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413188568
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID569436
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282217
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID488839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412563222
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2540252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ767J3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID855274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547251
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35396

Total number of triples: 86.